References
1. Niederman MS, Ferranti RD, Zeigler A, Merrill WW, Reynolds HY. 1984. Respiratory infection complicating long -term tracheostomy. The implication of persistent gram-negative tracheobronchial colonization.Chest . 85(1):39-44.
2. Toews GB, Hansen EJ, Strieter RM. 1990. Pulmonary host defenses and oropharyngeal pathogens. The American Journal of Medicine . 88(5, Supplement 1):S20-S24.
3. Yu H, Mamey MR, Russell CJ. 2017. Factors associated with 30-day all-cause hospital readmission after tracheotomy in pediatric patients.Int J Pediatr Otorhinolaryngol. 103:137-141.
4. Zhu H, Das P, Roberson DW, Jang J, Skinner ML, Paine M, Yuan J, Berry J. 2015. Hospitalizations in children with preexisting tracheostomy: A national perspective. The Laryngoscope . 125(2):462-468.
5. Russell CJ, Mamey MR, Koh JY, Schrager SM, Neely MN, Wu S. 2018. Length of stay and hospital revisit after bacterial tracheostomy-associated respiratory tract infection hospitalizations.Hosp Pediatr. 8(2):72-80.
6. Russell CJ, Mack WJ, Schrager SM, Wu S. 2017. Care variations and outcomes for children hospitalized with bacterial tracheostomy-associated respiratory infections. Hospital Pediatrics . 7(1):16-23.
7. Grosse-Onnebrink J, Rudloff J, Kessler C, Werner C, Dougherty GW, Kerschke L, Kahl BC, Omran H. 2019. Acinetobacter baumannii is a risk factor for lower respiratory tract infections in children and adolescents with a tracheostomy. Pediatr Infect Dis J . 38(10):1005-1009.
8. Russell CJ, Simon TD, Mamey MR, Newth CJL, Neely MN. 2017.Pseudomonas aeruginosa and post-tracheotomy bacterial respiratory tract infection readmissions. Pediatr Pulmonol . 52(9):1212-1218.
9. Sanders CD, Guimbellot JS, Muhlebach MS, Lin F-C, Gilligan P, Esther CR. 2018. Tracheostomy in children: Epidemiology and clinical outcomes.Pediatric Pulmonology . 53(9):1269-1275.
10. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B et al. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection . 18(3):268-281.
11. Rusakow LS, Guarin M, Wegner CB, Rice TB, Mischler EH. 1998. Suspected respiratory tract infection in the tracheostomized child: The pediatric pulmonologist’s approach. Chest. 113(6):1549-1554.
12. Goldman JL, Newland JG, Price M, Yu D, Lee BR. 2019. Clinical impact of an antimicrobial stewardship program on high-risk pediatric patients.Infect Control Hosp Epidemiol . 40(9):968-973.
13. CDC. 2019. Centers for Disease Control and Prevention: Antibiotic resistance threats in the United States, 2019. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf.
14. Murray MT, Beauchemin MP, Neu N, Larson EL. 2019. Prior antibiotic use and acquisition of multidrug-resistant organisms in hospitalized children: A systematic review. Infect Control HospEpidemiol . 40(10):1107-1115.
15. Chen G, Xu K, Sun F, Sun Y, Kong Z, Fang B. 2020. Risk factors of multidrug-resistant bacteria in lower respiratory tract infections: A systematic review and meta-analysis. Can J Infect Dis Med Microbiol. 2020:7268519.
16. Nathwani D, Raman G, Sulham K, Gavaghan M, Menon V. 2014. Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: A systematic review and meta-analysis. Antimicrob Resist Infect Control . 3(1):32.
17. Kuster SP, Hasse B, Huebner V, Bansal V, Zbinden R, Ruef C, Ledergerber B, Weber R. 2010. Risks factors for infections with extended-spectrum beta-lactamase-producing escherichia coli andKlebsiella pneumoniae at a tertiary care university hospital in switzerland. Infection . 38(1):33-40.
18. McLaren D, Chitakis M, Burns H, Kapur N. 2021. Airway microbiology in tracheostomized children. Respiratory Care. 66(2):281-285.
19. McCaleb R, Warren RH, Willis D, Maples HD, Bai S, O’Brien CE. 2016. Description of respiratory microbiology of children with long-term tracheostomies. Respir Care. 61(4):447-452.
20. Harlid R, Andersson G, Frostell CG, Jorbeck HJ, Ortqvist AB. 1996. Respiratory tract colonization and infection in patients with chronic tracheostomy. A one-year study in patients living at home.American journal of respiratory and critical care medicine.154(1):124-129.
21. Smith S, Rowbotham NJ, Regan KH. 2018. Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis. Cochrane Database of Systematic Reviews . (3).
22. Oermann CM, Retsch-Bogart GZ, Quittner AL, Gibson RL, McCoy KS, Montgomery AB, Cooper PJ. 2010. An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis. Pediatr Pulmonol . 45(11):1121-1134.
23. Burns JL, Van Dalfsen JM, Shawar RM, Otto KL, Garber RL, Quan JM, Montgomery AB, Albers GM, Ramsey BW, Smith AL. 1999. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis.179(5):1190-1196.
24. Laska IF, Crichton ML, Shoemark A, Chalmers JD. 2019. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: A systematic review and meta-analysis. The Lancet Respiratory Medicine. 7(10):855-869.